Town Hall to discuss potential merger with RSS
10am - 11 am
The BoD is in discussions with the Royal Statistical Society about a possible union.
While the discussions are at an early stage, the BoD believes that a merger could put extra resources behind PSI’s activities leading to greater reach for pharmaceutical statisticians. At this point, the union team would like to share with the membership the pros and cons that have been debated at the BoD and to to solicit feedback on our plans.
No votes or decisions will be taken at this meeting – the objective is to get a feel for the views of the membership to best inform our evaluation of the options in front of PSI.
Friday, February 5, 2016 10:00 AM - 11:00 AM GMT Standard Time
Please join the meeting from your computer, tablet or smartphone.
https://attendee.gotowebinar.com/register/1417555634070303745
Please ensure you allow sufficient time to install the GoToWebinar software (approximately 2 minutes).
After clicking the URL you will be sent a confirmation email giving you international phone numbers.
This course is aimed at clinical trial statisticians who are new to or with limited experience of machine learning. Attendees will learn about a range of topics in machine learning, including practical sessions in R.
This webinar will explore two different approaches to Correlates of Protection in vaccine development.
Our monthly webinar explores examples of innovative data visualisations relevant to our day to day work. Each month a new dataset is provided from a clinical trial or other relevant example, and participants are invited to submit a graphic that communicates interesting and relevant characteristics of the data.
The event will open with an overview on drug development in women’s health from a clinician perspective. This talk is followed by talks about statistical challenges when planning IVF studies and analysing the menstrual cycles.
This webinar will provide an overview of surrogacy for licensing and reimbursement. In turn, the need of extensions of the SPIRIT and CONSORT statement will be defined and outlined, with case studies to support.
Lea Vaas will present how replacement of concurrent control animals by Virtual Control Groups (VCGs) in systemic toxicity studies may help in contributing to the 3R's principle of animal experimentation: Reduce, Refine, Replace.
We will share a brief overview of what Mobilise D is and why it is an important step stone in the development of digital biomarkers, and how Mobilise D outputs can be relevant for you.
This networking event is aimed at statisticians that are new to the pharmaceutical industry who wish to meet colleagues from different companies and backgrounds.
This networking event is aimed at statisticians that are new to the pharmaceutical industry who wish to meet colleagues from different companies and backgrounds.
An introductory course giving an overview of the pharmaceutical industry and the drug development process as a whole, aimed at those with 1-3 years' experience. It comprises of six 2-day sessions covering a range of topics including Research and Development, Toxicology, Data Management and the Role of a CRO, Clinical Trials, Reimbursement, and Marketing.
This networking event is aimed at statisticians that are new to the pharmaceutical industry who wish to meet colleagues from different companies and backgrounds.
We have exciting new opportunities available for Study Statisticians, Support Statisticians and Exploratory Statisticians at various levels.
